Guest post by Joe Hoft at JoeHoft.com – republished with permission
The Psychiatric Drug Debate: Are Experts Afraid of Accountability?
Republished with permission from AbleChild.
Shortly after Donald Trump took office, he initiated the Make America Healthy Again Commission (MAHA) through an Executive Order, tasked with investigating the alarming trend of prescribing psychiatric medications like SSRIs, antipsychotics, and stimulants. This marks a much-needed scrutiny of what many perceive as rampant, unscientific chemical treatments for behavioral issues.
Finally, the government seems poised to confront the serious implications tied to mind-altering prescriptions. However, this initiative has left the mental health industry feeling uneasy, prompting them to release a joint statement extolling the virtues of these drugs.
In their defense, the industry claims these medications are essential for young patients, facilitating their participation in crucial developmental activities. This assertion, however, raises eyebrows.
For instance, the long-debunked idea of a “chemical imbalance” as the root of mental health issues was effectively challenged by researchers like Professor Joanna Moncrieff and Dr. Mark Horowitz in 2022. If the notion of chemical deficits is flawed, then why are these substances still being prescribed? Alarmingly, a staggering 77 million Americans were reported to be on at least one psychiatric drug as of 2020, a trend that includes thousands of very young children.
Consider, if you will, the prescribing of antidepressants to infants aged 0-1. The process raises significant questions: How can a baby, who cannot articulate feelings or symptoms, receive an accurate psychiatric diagnosis? As of 2020, nearly 8,000 infants were reported to be on antidepressants. It’s a scenario that would leave anyone scratching their head, if not outright horrified.
Even toddlers aged 2-3 are not spared, with over 12,000 being diagnosed with depression and subsequently prescribed antidepressants. The rationale behind such decisions is bewildering. How do doctors determine the efficacy of these drugs in children who cannot communicate their feelings? Did a toddler’s suddenly quiet demeanor signal improvement? The absurdity is hard to ignore.
This raises a critical point about the foundation of psychiatric diagnoses. They are often based on behavioral checklists rather than concrete scientific evidence. There are no blood tests or brain scans validating psychiatric disorders; it’s merely a subjective interpretation of behavior.
The mental health industry’s joint statement warns against discouraging the use of “evidence-based” treatments, yet fails to clarify that this “evidence” is often behavioral rather than scientific. The potential dangers of these medications are real and severe. For instance, the FDA mandates a Black Box warning for suicidality on all antidepressants. How reassuring is it to give children medications linked to suicidal tendencies?
Consider some potential side effects associated with commonly prescribed antidepressants:
Zoloft: Emotional instability, heightened depression, aggression, psychosis.
Prozac: Insomnia, agitation, hallucinations, mania.
Trazodone: Confusion, cognitive impairment, hallucinations, restlessness.
The data is telling: as the number of children diagnosed with mental disorders and prescribed medications rises, so too do incidents of suicide and self-harm. One must wonder where the “healthy” aspect fits into this alarming equation.
The irony deepens when we consider cases like that of Audrey Hale, the Covenant School shooter, who had been a psychiatric patient since childhood, subjected to a cocktail of medications for anxiety. Her tragic outcome serves as a stark reminder that these drugs may not lead to the promised “healthy” development.
Similarly, Lindsay Clancy, a mother prescribed 13 mind-altering drugs within two months, committed a shocking act of violence against her children. Yet, her psychiatrists have faced no accountability. This lack of responsibility extends to many horrific cases, where the psychiatric industry remains silent after such tragedies, seemingly shielded from scrutiny.
When a murder-suicide occurs, why is it so difficult to obtain information about the prescribed medications? If these treatments are as beneficial as claimed, shouldn’t there be transparency regarding their administration in such dire situations? Clancy’s drug records were only made public due to legal proceedings, raising further questions about the industry’s accountability.
Ultimately, the psychiatric industry cannot continue to tout the benefits of these drugs while simultaneously resisting transparency when things go terribly wrong. If Secretary Kennedy is committed to addressing America’s mental health crisis, he must ensure that information regarding psychiatric prescriptions is made public, particularly in the context of violent incidents. The time for the psycho-pharmaceutical industry to be held accountable for its practices is long overdue.
Be the Voice for the Voiceless
What Can You Do? Sign the Petition calling for federal hearings!
Donate! Every dollar you contribute is a powerful statement, a resounding declaration that the struggles of these families will no longer be overlooked. Your generosity today will ensure that the rights and well-being of children are fiercely protected. Don’t let another family navigate this journey alone. Donate now and join us in creating a world where every child’s mind is nurtured, respected, and given the opportunity to thrive. As a 501(c)3 organization, your donation to AbleChild is not only an investment in the well-being of vulnerable children but also a tax-deductible contribution to a cause that transcends individual lives.
